Again, this primarily occurs through IFN-mediated reduction in VEGFA and HIF1α transcription, with lower levels of VEGF mRNA detected in tumour samples following Type I IFN therapy, as compared to diagnostic samples (52, 56). The gene discussed is VEGFA; the disease is neoplasm.